Insights

Underserved market focus nContact targets the underserved arrhythmia market with less invasive, more efficacious ablation alternatives, presenting growth opportunities in hospitals and outpatient centers seeking advanced AF treatment options.

Innovative lead tech Key products EPi-Sense and Numeris Coagulation System with VisiTrax offer CE mark in Europe and U.S. indications, enabling cross‑regional sales pitches to electrophysiology labs seeking proven, cutting-edge ablation solutions.

Regulatory momentum CE mark approvals in Europe and U.S. indications for endoscopic coagulation support faster country-by-country expansion plans and partner outreach for international deployments.

Financial outreach With annual revenue in the low-to-mid multi‑millions and a substantial funding runway, there is capacity for co‑development deals, channel partnerships, and targeted pilots to accelerate adoption.

Strategic partnerships Small but focused team size suggests value in channel partnerships with major distributors and contract manufacturers to scale training, service, and installation for hospital networks.

nContact, Inc. Email Formats	Example	Percentage
FLast@ncontactinc.com	JDoe@ncontactinc.com	85%
First.Last@ncontactinc.com	John.Doe@ncontactinc.com	15%

nContact, Inc. Email Formats

Example

Percentage

FLast@ncontactinc.com

JDoe@ncontactinc.com

85%

First.Last@ncontactinc.com

John.Doe@ncontactinc.com

15%

Frequently Asked Questions

What is nContact, Inc.'s phone number?

You can contact nContact, Inc.'s main corporate office by phone at

+1-919-466-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is nContact, Inc.'s official website and social media links?

nContact, Inc.'s official website is ncontactinc.com and has social profiles on LinkedIn.

How much revenue does nContact, Inc. generate?

As of July 2026, nContact, Inc.'s annual revenue is estimated to be $1M - $10M.

What is nContact, Inc.'s NAICS code?

nContact, Inc.'s NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does nContact, Inc. have currently?

As of July 2026, nContact, Inc. has approximately 11 employees across 1 continents, including North America. Key team members include Vice President, Logistics: G. B. Explore nContact, Inc.'s employee directory with LeadIQ.

What industry does nContact, Inc. belong to?

nContact, Inc. operates in the Medical Devices industry.

What is nContact, Inc.'s email format?

nContact, Inc.'s email format typically follows the pattern of FLast@ncontactinc.com. Find more nContact, Inc. email formats with LeadIQ.

How much funding has nContact, Inc. raised to date?

As of July 2026, nContact, Inc. has raised $75M in funding. The last funding round occurred on Nov 13, 2014.

nContact, Inc.

Q: What is nContact, Inc.'s official website and social media links?

nContact, Inc.'s official website is ncontactinc.com. nContact, Inc. has social profiles on LinkedIn.

Q: How many employees does nContact, Inc. have currently?

nContact, Inc. has approximately 11 employees.

Q: What is nContact, Inc.'s NAICS code?

nContact, Inc.'s NAICS code is 3391 (Medical Equipment and Supplies Manufacturing).

Medical DevicesNorth Carolina, United States11-50 Employees

nContact, Inc. is a medical equipment manufacturer focused on developing epicardial ablation devices and techniques aimed at improving treatment options for cardiac arrhythmias, particularly atrial fibrillation. The company's products are designed to provide less invasive and potentially more effective alternatives for ablation, addressing a market that is underserved in this therapeutic area. Based in Morrisville, North Carolina, nContact was founded in 2005 and operates within the medical device industry, serving clinicians and healthcare facilities seeking innovative approaches to arrhythmia management. The organization has a presence in Europe through CE Mark approvals for its coagulation therapies and also indicates US indications for endoscopic coagulation, reflecting its international regulatory footprint in the cardiac tissue coagulation space.

Insights

Similar companies to nContact, Inc.

Abbott

Medtronic

Boston Scientific

nContact, Inc.'s Email Address Formats